Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Country / region: Canada Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20081
20092
20122
20131
20144
20161
20181
20201
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Enrolling by invitation1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Chugai Pharmaceutical2
GlaxoSmithKline2
Principia Biopharma, a Sanofi Company2
Rigel Pharmaceuticals2
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Boston Children's Hospital1
Bristol-Myers Squibb1
Grifols Biologicals, LLC1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic21
Thrombocytopenia9
Purpura4
Hemorrhage3
Antiphospholipid Syndrome2
Behcet Syndrome2
Dermatomyositis2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic2
Anemia, Hemolytic1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.